Showing results (71-80 of 129) with videos related to
Sort By:
Pageof 13
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1983
Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodiesP A Keep, F Searle, R H Begent, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibodyA Mayer, K A Chester, J Bhatia, et al.British Journal of Cancer|December 1, 1994
The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibodyR B Pedley, J A Boden, R Boden, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trialJ Martin, S M Stribbling, G K Poon, et al.British Journal of Urology|August 1, 1994
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumoursJ A Ledermann, L Holden, E S Newlands, et al.International Journal of Cancer|April 15, 1984
Preparation and properties of mouse monoclonal antibody (W14A) to human chorionic gonadotropinF Searle, C S Partridge, A Kardana, et al.Lancet (London, England)|August 24, 1991
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyD B Smith, E S Newlands, G J Rustin, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapyD B Smith, E S Newlands, G J Rustin, et al.Cancer Research|July 15, 1996
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agentsR B Pedley, J A Boden, R Boden, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 2, 1998
The management of high-risk gestational trophoblastic tumours (GTT)E S Newlands, M Bower, L Holden, et al.Pageof 13